Osteoblend
Natural health product licensed in Canada
- Licence holder
- Vitanica
- NPN or DIN-HM
- 80070466
- Status
- Active licence
- Licence date
- 20 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 50,000 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 8 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Sélénium: up to 50,000 µg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (255 µg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Information
Vitamine K: the published amount (50 milligramme) is more than a thousand times the maximum supplement dose: this is very likely a unit error in the source. No dose comparison is made for this nutrient.
contrôle de vraisemblance. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine-5-phosphate | 5 milligramme | 10,000 µg |
| Vitamine D Source : Ergocalciférol | 200 UI | 10 µg |
| Vitamine D Source : Ergocalciférol | 5 microgrammes | Not calculated |
| Vitamin K1 Source : Vitamine K1 | 50 milligramme | 100,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 5 milligramme | 10,000 µg |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 100 microgrammes | Not calculated |
| Calcium Source : Citrate de calcium | 150 milligramme | 300,000 µg |
| Calcium Source : Malate de calcium | 150 milligramme | 300,000 µg |
| Calcium Source : Carbonate de calcium | 150 milligramme | 300,000 µg |
| Magnésium Source : Citrate de magnésium | 75 milligramme | 150,000 µg |
| Zinc Source : Picolinate de zinc | 6.5 milligramme | 13,000 µg |
| Sélénium Source : Sélénométhionine | 25 milligramme | 50,000 µg |
| Cuivre Source : Gluconate de cuivre (II) | 375 microgrammes | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 4 milligramme | 8,000 µg |
| Boron Source : Boron hydrolyzed vegetable protein (HVP) chelate | 0.75 milligramme | Not calculated |
| Silicium Source : Produit de chélation de silicium et de protéine animale hydrolysée (PAH) | 25 microgrammes | Not calculated |
Non-medicinal ingredients
Hypromellose, cellulose, L-leucine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps to build strong bones and teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070466
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.